Search 33,000+ CME courses
Back

StatPearls, LLC

  • Angina Pectoris, Variant
  • Angina, Stable
  • Angiotensin-Converting Enzyme Inhibitors
  • Hypertension
  • Nisoldipine

Nisoldipine

Nisoldipine, a dihydropyridine calcium channel blocker, is a drug used for the management of hypertension. This medication exerts its therapeutic effects by inhibiting calcium influx and blocking voltage-gated calcium channels in systemic smooth muscle cells. By reducing calcium levels, nisoldipine dilates coronary and systemic arteries. According to the American College of Cardiology/American Heart Association guidelines, nisoldipine is recommended as a first-line therapy for hypertension. It can be used as a standalone treatment or with other antihypertensive agents, such as angiotensin-converting enzyme inhibitors, diuretics, or beta-blockers. Additionally, this drug exhibits potential off-label applications for addressing ischemic heart conditions, including stable angina and Prinzmetal angina. This activity explores nisoldipine’s indications, contraindications, adverse effects, and essential factors such as dosing, pharmacodynamics, pharmacokinetics, monitoring, and pertinent interactions.

Credit & MOC Details

Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.

Credit types

AAPA Category 1 Credit™Up to 1 creditAMA PRA Category 1 Credit™Up to 1 creditNursingUp to 1 creditPharmacyUp to 1 credit

MOC types

ABS — Accredited CMEUp to 1 pointABPATH — Lifelong LearningUp to 1 pointABA — Lifelong LearningUp to 1 pointABTS — Accredited CMEUp to 1 pointABIM — Medical KnowledgeUp to 1 pointABS — Self-AssessmentUp to 1 pointABTS — Self-AssessmentUp to 1 point

FDA REMS

No

Qualifies for MIPS

No

Target Specialties

Pricing

Fee varies

This provider typically $49–98

See fees on statpearls.com

Listed by the provider

  • Article / monograph / reference
  • Credit · Up to 1 credit
  • MOC · Up to 1 point
  • Fee varies · this provider typically $49–98
  • Released
    Sep 1, 2026
  • Last day to claim credit
    Sep 1, 2029 3 years left

More from StatPearls, LLC

See all

This provider’s courses closest to this one